Neuropharmacology
Neuropharmacology
0028-3908
Pergamon Press


2194164
17714744
NP3171
10.1016/j.neuropharm.2007.07.003
Article


1
 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2

Németh
Beáta

a

Ledent
Catherine

b

Freund
Tamás F.

a

Hájos
Norbert

hajos@koki.hu
a
∗


a
Institute of Experimental Medicine, Hungarian Academy of Sciences, Szigony u. 43, Budapest H-1450, Hungary

b
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moleculaire, Universite Libre de Bruxelles, 1070 Brussels, Belgium

∗
hajos@koki.hu


1
2008

54
1
51
57
26
3
2007

27
6
2007

4
7
2007


© 2008 Elsevier Ltd.
2007
Elsevier Ltd
certain conditions
.


Abstract
1
1
1
1
1
R-independent effect of 10 μM WIN 55,212-2 at glutamatergic synapses was fully abolished, when slices were pre-treated with ω-conotoxin GVIA, but not with ω-agatoxin IVA.
1
1
2+
1
Rs.

Keywords
Brain slices
Glutamate
Transmitter release
Hippocampus
Pyramidal cell
Cannabinoids



1
Introduction
1
Freund et al., 2003
1
Katona et al., 1999, 2006; Kawamura et al., 2006
1
Nyiri et al., 2005; Kawamura et al., 2006
1
2+
2+
Wilson et al., 2001; Diana and Marty, 2003
).
1
1
1
Hájos et al., 2001
Hoffman and Lupica, 2000; Ohno-Shosaku et al., 2002; Hájos and Freund, 2002
1
1
Hájos and Freund, 2002
1
1
Ohno-Shosaku et al., 2002; Domenici et al., 2006; Takahashi and Castillo, 2006
).
1
Hájos et al., 2005
).

2
Methods
1
3
2
2
2
4
2
2
3
2
2
2
4
, and 10 glucose) at room temperature for at least 1 h before recording. After the initial incubation period, slices were transferred individually into a submerged type recording chamber.
2
Hájos et al., 2005
http://www.superte.ch
). Access resistances (between 4 and 18 MΩ, compensated 65–70%) were frequently monitored and remained constant (±20%) during the period of analysis. Signals were recorded with a Multiclamp 700A (Molecular Devices, Sunnyvale, CA), filtered at 2 kHz, digitized at 6 kHz (National Instruments PCI-6024E A/D board, Austin, TX), and analyzed off-line with the EVAN program (courtesy of Prof. I. Mody, UCLA, CA).
n
50
f
x
a
x
c
b
a
x
e
d
c
e
f
x
a
x
c
b
c
50
tatistica
 6.1 (Statsoft, Inc., Tulsa, OK). Data are presented as mean ± SEM.
Picrotoxin, WIN 55,212-2 and WIN 55,212-3 were purchased from Sigma-Aldrich, AM251 was obtained from Tocris, while ω-conotoxin GVIA and ω-agatonix IVA from Alomone Labs. For all experiments, WIN-55,212-2 was dissolved in 0.1N HCl giving a 20 mM stock solution stored at 4 °C. AM251 was dissolved in DMSO (100 mM) and stored at −20 °C. WIN 55,212-3 dissolved in DMSO (100 mM) was stored at 4 °C. From these stock solutions, the final dilution of drugs was done in ACSF containing picrotoxin under constant stirring and the prepared solution was bath applied. In control solutions, the vehicle was diluted in the same concentration as in the solutions containing drugs. Bovine serum albumin (BSA) was added in a concentration of 0.1 mg/ml to the solutions used for experiments with WIN 55,212-3.

3
Results
Fig. 1
50
Fig. 1
1
Fig. 1
50
Fig. 1
c).
Fig. 1
50
Fig. 1
1
1
Fig. 1
50
Fig. 1
c).
1
1
R-dependent and -independent effect on glutamatergic transmission at Schaffer collateral synapses.
1
1
Fig. 2
n
p
1
1
n
p
Figs. 2
n
p
n
p
1
Figs. 2
n
p
1
Figs. 2
n
p
1
R-independent effect of WIN 55,212-2 also appears to be presynaptic, reducing glutamate release from Schaffer collateral terminals.
Shen and Thayer, 1998
2+
1
n
n
Fig. 1
n
n
p
U
1
2+
 entry into the presynaptic boutons.
1
2+
2+
2+
n
p
Fig. 3
n
p
Fig. 3
1
2+
 channels.

4
Discussion
1
1
1
2+
1
Rs.
Shen et al., (1996)
Misner and Sullivan, 1999; Al-Hayani and Davies, 2000; Hájos and Freund, 2002; Ohno-Shosaku et al., 2002; Hoffman et al., 2003
Levenes et al., 1998; Takahashi and Linden, 2000
Domenici et al., 2006
Azad et al., 2003; Domenici et al., 2006
Gerdeman and Lovinger, 2001; Huang et al., 2001
1
Katona et al., 1999; Hájos et al., 2000
1
Hájos et al., 2001; Kofalvi et al., 2003
1
Katona et al., 1999; Hájos et al., 2000; Nyiri et al., 2005
1
Hájos et al., 2000, 2001; Varma et al., 2001; Wilson et al., 2001
Hájos and Freund (2002)
1
Katona et al., 2006; Kawamura et al., 2006
1
1
Ohno-Shosaku et al., 2002; Domenici et al., 2006; Takahashi and Castillo, 2006
1
2+
1
Shen and Thayer, 1998; Kofalvi et al., 2007
1
Ohno-Shosaku et al., 2002
1
1
Kawamura et al., 2006
1
Hoffman et al. (2005)
1
Domenici et al., 2006; Takahashi and Castillo, 2006
). The explanation for these negative findings remains to be investigated.
Takahashi and Linden, 2000; Robbe et al., 2001; Hájos and Freund, 2002; Hoffman et al., 2005
1
Hájos et al., 2005
Ohno-Shosaku et al., 2002
Felder et al., 1995
).
1
Hájos et al., 2001; Pistis et al., 2004; Kofalvi et al., 2005; Matyas et al., 2006
2+
Shen and Thayer, 1998; Kofalvi et al., 2007
1
2+
 channels.
1
1
2+
Wilson et al., 2001
1
n
1
n
n
Hájos and Freund, 2002
1
1
2+
1
2+
 channels. Testing this hypothesis, and other novel aspects of cannabinoid modulation of GABAergic transmission is the subject of another line of investigations in our laboratory.
1
2+
2+
1
Chemin et al., 2001; Fisyunov et al., 2006
1
Ohno-Shosaku et al., 2002; Straiker and Mackie, 2005
Rouach and Nicoll, 2003
1
2+
Haller et al., 2007
).


Acknowledgements
This work was supported by the Howard Hughes Medical Institute, by EU (LSHM-CT-2004-005166), NKFP 1A/002/2004, OTKA Hungary (T46820), and NIH (NS30549). N.H. is the recipient of a Wellcome Trust International Senior Research Fellowship. We thank Dr. István Katona for advice and comments on the manuscript, and Dr. Szabolcs Káli for help with curve fitting. The excellent technical assistance of Katalin Lengyel, Emőke Simon and Katalin Iványi is also gratefully acknowledged.

References
Al-Hayani and Davies, 2000
Al-Hayani
A.

Davies
S.N.


Cannabinoid receptor mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated
British Journal of Pharmacology
2000
131
663
665
11030713


Azad et al., 2003
Azad
S.C.

Eder
M.

Marsicano
G.

Lutz
B.

Zieglgansberger
W.

Rammes
G.


Activation Of The Cannabinoid Receptor Type 1 Decreases Glutamatergic And Gabaergic Synaptic Transmission In The Lateral Amygdala Of The Mouse
Learning & Memory
vol. 10
2003
Cold Spring Harbor
NY
pp. 116–128


Chemin et al., 2001
Chemin
J.

Monteil
A.

Perez-Reyes
E.

Nargeot
J.

Lory
P.


Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
EMBO Journal
2001
20
7033
7040
11742980


Diana and Marty, 2003
Diana
M.A.

Marty
A.


Characterization of depolarization-induced suppression of inhibition using paired interneuron—Purkinje cell recordings
Journal of Neuroscience
2003
23
5906
5918
12843295


Domenici et al., 2006
Domenici
M.R.

Azad
S.C.

Marsicano
G.

Schierloh
A.

Wotjak
C.T.

Dodt
H.U.

Zieglgansberger
W.

Lutz
B.

Rammes
G.


Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission
Journal of Neuroscience
2006
26
5794
5799
16723537


Felder et al., 1995
Felder
C.C.

Joyce
K.E.

Briley
E.M.

Mansouri
J.

Mackie
K.

Blond
O.

Lai
Y.

Ma
A.L.

Mitchell
R.L.


Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors
Molecular Pharmacology
1995
48
443
450
7565624


Fisyunov et al., 2006
Fisyunov
A.

Tsintsadze
V.

Min
R.

Burnashev
N.

Lozovaya
N.


Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons
Journal of Neurophysiology
2006
96
1267
1277
16738209


Freund et al., 2003
Freund
T.F.

Katona
I.

Piomelli
D.


The role of endogenous cannabinoids in synaptic signaling
Physiological Reviews
2003
83
1017
1066
12843414


Gerdeman and Lovinger, 2001
Gerdeman
G.

Lovinger
D.M.


CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum
Journal of Neurophysiology
2001
85
468
471
11152748


Hájos and Freund, 2002
Hájos
N.

Freund
T.F.


Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers
Neuropharmacology
2002
43
503
510
12367597


Hájos et al., 2000
Hájos
N.

Katona
I.

Naiem
S.S.

MacKie
K.

Ledent
C.

Mody
I.

Freund
T.F.


Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
European Journal of Neuroscience
2000
12
3239
3249
10998107


Hájos et al., 2001
Hájos
N.

Ledent
C.

Freund
T.F.


Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
Neuroscience
2001
106
1
4


Hájos et al., 2005
Hájos, N., Mann, E.O., Freund, T.F., Paulsen, O., 2005. Oxygen content of extracellular solution determines the stability of network oscillations in submerged hippocampal slices. 35th Society for Neuroscience Meeting, 275.18.

Haller et al., 2007
Haller
J.

Mátyás
F.

Soproni
K.

Varga
B.

Barsy
B.

Németh
B.

Mikics
É.

Freund
T.F.

Hájos
N.


Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic/glutamatergic synaptic transmission
European Journal of Neuroscience
2007
25
2445
2456
17445240


Hoffman and Lupica, 2000
Hoffman
A.F.

Lupica
C.R.


Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus
Journal of Neuroscience
2000
20
2470
2479
10729327


Hoffman et al., 2003
Hoffman
A.F.

Riegel
A.C.

Lupica
C.R.


Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus
European Journal of Neuroscience
2003
18
524
534
12911748


Hoffman et al., 2005
Hoffman
A.F.

Macgill
A.M.

Smith
D.

Oz
M.

Lupica
C.R.


Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus
European Journal of Neuroscience
2005
22
2387
2391
16262678


Huang et al., 2001
Huang
C.C.

Lo
S.W.

Hsu
K.S.


Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons
Journal of Physiology
2001
532
731
748
11313442


Katona et al., 1999
Katona
I.

Sperlagh
B.

Sik
A.

Kafalvi
A.

Vizi
E.S.

Mackie
K.

Freund
T.F.


Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons
Journal of Neuroscience
1999
19
4544
4558
10341254


Katona et al., 2006
Katona
I.

Urban
G.M.

Wallace
M.

Ledent
C.

Jung
K.M.

Piomelli
D.

Mackie
K.

Freund
T.F.


Molecular composition of the endocannabinoid system at glutamatergic synapses
Journal of Neuroscience
2006
26
5628
5637
16723519


Kawamura et al., 2006
Kawamura
Y.

Fukaya
M.

Maejima
T.

Yoshida
T.

Miura
E.

Watanabe
M.

Ohno-Shosaku
T.

Kano
M.


The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum
Journal of Neuroscience
2006
26
2991
3001
16540577


Kofalvi et al., 2003
Kofalvi
A.

Vizi
E.S.

Ledent
C.

Sperlagh
B.


Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action
European Journal of Neuroscience
2003
18
1973
1978
14622229


Kofalvi et al., 2005
Kofalvi
A.

Rodrigues
R.J.

Ledent
C.

Mackie
K.

Vizi
E.S.

Cunha
R.A.

Sperlágh
B.


Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis
Journal of Neuroscience
2005
25
2874
2884
15772347


Kofalvi et al., 2007
Kofalvi
A.

Pereira
F.M.

Rebola
N.

Rodrigues
R.J.

Oliveira
C.R.

Cunha
R.A.


Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus
British Journal of Pharmacology
2007
151
551
563
17435795


Levenes et al., 1998
Levenes
C.

Daniel
H.

Soubrie
P.

Crepel
F.


Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells
Journal of Physiology
1998
510
867
879
9660899


Matyas et al., 2006
Matyas
F.

Yanovsky
Y.

Mackie
K.

Kelsch
W.

Misgeld
U.

Freund
T.F.


Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia
Neuroscience
2006
137
337
361
16289348


Misner and Sullivan, 1999
Misner
D.L.

Sullivan
J.M.


Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons
Journal of Neuroscience
1999
19
6795
6805
10436037


Nyiri et al., 2005
Nyiri
G.

Cserep
C.

Szabadits
E.

Mackie
K.

Freund
T.F.


CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons
Neuroscience
2005
136
811
822
16344153


Ohno-Shosaku et al., 2002
Ohno-Shosaku
T.

Tsubokawa
H.

Mizushima
I.

Yoneda
N.

Zimmer
A.

Kano
M.


Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses
Journal of Neuroscience
2002
22
3864
3872
12019305


Pistis et al., 2004
Pistis
M.

Perra
S.

Pillolla
G.

Melis
M.

Gessa
G.L.

Muntoni
A.L.


Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions
Neuropharmacology
2004
46
115
125
14654103


Robbe et al., 2001
Robbe
D.

Alonso
G.

Duchamp
F.

Bockaert
J.

Manzoni
O.J.


Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens
Journal of Neuroscience
2001
21
109
116
11150326


Rouach and Nicoll, 2003
Rouach
N.

Nicoll
R.A.


Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus
European Journal of Neuroscience
2003
18
1017
1020
12925027


Shen and Thayer, 1998
Shen
M.

Thayer
S.A.


The cannabinoid agonist Win 55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons
Brain Research
1998
783
77
84
9479052


Shen et al., 1996
Shen
M.

Piser
T.M.

Seybold
V.S.

Thayer
S.A.


Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures
Journal of Neuroscience
1996
16
4322
4334
8699243


Straiker and Mackie, 2005
Straiker
A.

Mackie
K.


Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones
Journal of Physiology
2005
569
501
517
16179366


Takahashi and Castillo, 2006
Takahashi
K.A.

Castillo
P.E.


The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus
Neuroscience
2006
139
795
802
16527424


Takahashi and Linden, 2000
Takahashi
K.A.

Linden
D.J.


Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells
Journal of Neurophysiology
2000
83
1167
1180
10712447


Varma et al., 2001
Varma
N.

Carlson
G.C.

Ledent
C.

Alger
B.E.


Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus
Journal of Neuroscience
2001
4
4


Wilson et al., 2001
Wilson
R.I.

Kunos
G.

Nicoll
R.A.


Presynaptic specificity of endocannabinoid signaling in the hippocampus
Neuron
2001
31
453
462
11516401




Fig. 1
1
a
b
1
1
c
1
R knockout mice. Data obtained after application of the inactive enantiomer WIN 55,212-3 (WIN-3) are also included on the left graph.



Fig. 2
1
a
b
1
c
, The paired-pulse ratios (PPR) calculated from each recordings in control conditions (ctr) and after drug application are presented for corresponding experiments.



Fig. 3
1
2+
1
a
b
1
2+
 channels are required for presynaptic inhibition by this cannabinoid compound applied in high doses.





